- Report
- May 2025
- 184 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 194 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 194 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- August 2024
- 141 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- December 2024
- 152 Pages
Global
From €3538EUR$3,950USD£3,016GBP
- Report
- July 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2687EUR$3,000USD£2,291GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- April 2025
- 186 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- May 2025
- 196 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- March 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1791EUR$2,000USD£1,527GBP
- Report
- December 2024
- 70 Pages
Global
From €3578EUR$3,995USD£3,050GBP
- Report
- May 2025
- 198 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 278 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- December 2024
- 30 Pages
Global
From €2463EUR$2,750USD£2,100GBP
- Report
- December 2024
- 30 Pages
Global
From €2463EUR$2,750USD£2,100GBP
- Report
- December 2024
- 30 Pages
Global
From €2463EUR$2,750USD£2,100GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more